Systemic treatment for renal cell carcinoma: an overview.
Swanson
D A
DA
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000628:therapy; D002940:Circadian Rhythm; D006224:Cricetinae; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation; D008081:Liposomes; D008647:Mesocricetus; D051379:Mice; D008819:Mice, Nude; D009857:Oncogenes; D011379:Prognosis
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D012739:Gonadal Steroid Hormones; D007155:Immunologic Factors; D008081:Liposomes